Verrica Pharmaceuticals

$7.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-2.76%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell VRCA and other stocks, options, and ETFs commission-free!

About VRCA

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. Read More The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA. The listed name for VRCA is Verrica Pharmaceuticals Inc. Common Stock.

CEO
Ted White
Employees
17
Headquarters
West Chester, Pennsylvania
Founded
2013
Market Cap
191.29M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.04K
High Today
$7.62
Low Today
$7.05
Open Price
$7.54
Volume
62.78K
52 Week High
$18.58
52 Week Low
$6.02

Collections

VRCA Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 13, After Hours

You May Also Like